S-Alpha Therapeutics. Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2019

Location

Seoul South Korea

Primary Industry

Healthcare IT

About

Founded in 2019 and based in Seoul, South Korea, S-ALPHA THERAPEUTICS. Inc. operates as a developer of digital therapeutics and health applications that help patients with chronic diseases such as diabetes and mental illnesses. In November 2020, the company raised USD 2.7 million in seed funding. The company was certificated as Company Affiliated Research Institute by Korea Institute for Advancement of Technology. The pipelines manufactured by the company are SAT-001, SAT-002, SAT-006, SAT-008 and SAT-003. These pipelines can be used in ophthalmology, neurology, oncology, gastroenterology and public crisis. The company has cooperated with LegoChemBio, Stonebridge and other enterprises.

Current Investors

Ligachem Bioscience Co., Ltd., AJU IB Investment, SJ Investment Partners

Request a demo to show more

Primary Industry

Healthcare IT

Sub Industries

Healthcare IT, Medical Software

Website

www.salphadtx.com

Verticals

HealthTech, Mobile Apps

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.